These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 20150544
1. Cystatin C and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis. Hoke M, Amighi J, Mlekusch W, Schlager O, Exner M, Sabeti S, Dick P, Koppensteiner R, Minar E, Rumpold H, Wagner O, Schillinger M. Stroke; 2010 Apr; 41(4):674-9. PubMed ID: 20150544 [Abstract] [Full Text] [Related]
3. Cystatin C and the risk of death and cardiovascular events among elderly persons. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C. N Engl J Med; 2005 May 19; 352(20):2049-60. PubMed ID: 15901858 [Abstract] [Full Text] [Related]
4. Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality. Rebholz CM, Grams ME, Matsushita K, Inker LA, Foster MC, Levey AS, Selvin E, Coresh J. Clin J Am Soc Nephrol; 2015 Jun 05; 10(6):941-8. PubMed ID: 25825481 [Abstract] [Full Text] [Related]
5. A new marker of carotid atherosclerosis in middle aged adults: cystatin C or microalbuminuria. Nand N, Jain R, Seth S, Sen J, Sharma M. Indian Heart J; 2010 Jun 05; 62(4):320-3. PubMed ID: 21280472 [Abstract] [Full Text] [Related]
6. Effect of cystatin C levels on angiographic atherosclerosis progression and events among postmenopausal women with angiographically decompensated coronary artery disease (from the Women's Angiographic Vitamin and Estrogen [WAVE] study). Patel D, Ahmad S, Silverman A, Lindsay J. Am J Cardiol; 2013 Jun 15; 111(12):1681-7. PubMed ID: 23499273 [Abstract] [Full Text] [Related]
8. Microalbuminuria, but not cystatin C, is associated with carotid atherosclerosis in middle-aged adults. Rodondi N, Yerly P, Gabriel A, Riesen WF, Burnier M, Paccaud F, Bovet P. Nephrol Dial Transplant; 2007 Apr 15; 22(4):1107-14. PubMed ID: 17205961 [Abstract] [Full Text] [Related]
9. The relationship of cystatin C, creatinine, estimated GFR, and cardiovascular events. Zhang L, Ni L, Lv J. J Huazhong Univ Sci Technolog Med Sci; 2010 Dec 15; 30(6):699-703. PubMed ID: 21181357 [Abstract] [Full Text] [Related]
11. Serum cystatin C is associated with kidney function but not with cardiovascular risk factors or subclinical atherosclerosis in patients with Systemic Lupus Erythematosus. Garcia-Garcia P, Castejon R, Tutor-Ureta P, Silvestre RA, Mellor-Pita S, Jimenez-Ortiz C, Yebra-Bango M. Clin Rheumatol; 2017 Dec 15; 36(12):2709-2717. PubMed ID: 28914371 [Abstract] [Full Text] [Related]
18. Cystatin C-based eGFR is a superior prognostic parameter to creatinine-based eGFR in post-endovascular therapy peripheral artery disease patients. Otaki Y, Takahashi H, Watanabe T, Yamaura G, Funayama A, Arimoto T, Shishido T, Miyamoto T, Kubota I. Circ J; 2015 Dec 15; 79(11):2480-6. PubMed ID: 26354502 [Abstract] [Full Text] [Related]
19. Cystatin C and creatinine as markers of bleeding complications, cardiovascular events and mortality during oral anticoagulant treatment. Lind M, Jansson JH, Nilsson TK, Järvholm LS, Johansson L. Thromb Res; 2013 Aug 15; 132(2):e77-82. PubMed ID: 23834818 [Abstract] [Full Text] [Related]